GE HealthCare Technologies Inc. (GEHC)

Market Cap	35.70B
Revenue (ttm)	20.25B
Net Income (ttm)	2.22B
Shares Out	456.56M
EPS (ttm)	4.83
PE Ratio	16.19
Forward PE	16.25
Dividend	$0.14 (0.18%)
Ex-Dividend Date	Oct 24, 2025

Volume	5,180,744
Open	76.74
Previous Close	79.40
Day's Range	73.73 - 78.32
52-Week Range	57.65 - 94.80
Beta	1.28
Analysts	Buy
Price Target	84.89 (+8.57%)
Earnings Date	Oct 29, 2025

About GEHC

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1892
• Employees: 53,000
• Stock Exchange: NASDAQ
• Ticker Symbol: GEHC
• Website: https://www.gehealthcare.com

Financial Performance

In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.

Analyst Summary

According to 9 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price target is $84.89, which is an increase of 8.57% from the latest price.

Price Target

$84.89

(8.57% upside)

Analyst Consensus: Buy